Talk to an expert
Envelope Linkedin

Explore Starodub latest updates

Get in touch
View our whitepapers
  • Updates

Looking for regulatory expertise to move your (Bio)Pharmaceutical project forward?
  • Updates

28 May is almost here — is your organization EUDAMED‑ready?
  • Updates

Key revisions of Policy Document for Parallel Import of Medicines
  • Updates

Before strategy is written, it is already made
  • Updates

EMA Centralised Procedure – Analysis of Marketing Authorisation Applications
  • Updates

Respiratory Syncytial Virus (RSV) and its growing public health impact.
  • Updates

EMA strengthens PRIME: New tools to accelerate breakthrough medicines in Europe
  • Updates

EMA Updates Guideline on Chemistry of Active Substances
  • Updates

Starodub participation in the 21st BIO KOREA International Convention
  • Updates

CMDh updates Q&A on Generic Drug Submissions – What you need to know?
  • Updates

Dutch Biotech Mission to BIO KOREA 2026
  • Updates

New QP service
  • Updates

How do you achieve good clinical practice under the EU Medical Device Regulation 2017/745?
  • Updates

Why benefit–risk and reimbursement assessments can differ
  • Updates

CE marking for Start-ups and small manufacturers
  • Updates

A First Look at the Future of CMC Documentation in ICH M4Q(R2)
  • Updates

EU GMP Annex 15 – Qualification & Validation, public consultation started
  • Updates

Roses are red. Violets are blue.Non-compliance is costly… but Starodub has got you covered.
Load more updates
Jolanda Lamers-Lemmers
Management team member - Senior RA Consultant
Jolanda Lamers-Lemmers

Let's Connect

Talk to an expert